This dual strategy—developing serum-free media and engineering immortalized cell lines—addresses two of the most pressing challenges in cultured meat production: cost reduction and stable scalability.

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to produce its own insulin. A new technology developed by scientists at the ...

Cancer immunotherapy is a strategy that turns the patient’s own immune cells into a “search-and-destroy” force that attacks the tumor’s cells. The “search” immune cells are the dendritic cells, which ...

Kraig says it now has the potential commercial reach of the company’s core technologies beyond recombinant spider silk fibers ...

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have ...

Michel Sadelain, a global pioneer in CAR T-cell immunotherapy, will head the new Columbia Initiative in Cell Engineering and Therapy. Interim University President Katrina Armstrong announced the ...

Collaborative research defines a novel approach to understanding how certain proteins called transcription factors determine which genetic programs will drive cell growth and maturation. The method, ...

WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...